Evidence map›Paper›PMID 42248875›Full record

ArticleCell death discovery2026

Novel truncating Desmin mutation Arg150Stop disrupts structural integrity and cellular homeostasis by formation of persistent aggregate-like structure.

Sukanya Mitra, Trisha Ghosh, Arun Kumar Mishra, Shamita Sanga, Sai Gayathri R, Mahua Maulik, Moulinath Acharya

Abstract read
In one paragraph

Article in Cell death discovery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sukanya MitraBRIC-National Institute of Biomedical Genomics, Kalyani, India.
Trisha GhoshBRIC-National Institute of Biomedical Genomics, Kalyani, India.
Arun Kumar MishraBRIC-National Institute of Biomedical Genomics, Kalyani, India.
Shamita SangaBRIC-National Institute of Biomedical Genomics, Kalyani, India.
Sai Gayathri RBRIC-National Institute of Biomedical Genomics, Kalyani, India.
Mahua MaulikBRIC-National Institute of Biomedical Genomics, Kalyani, India. mm1@nibmg.ac.in.
Moulinath AcharyaBRIC-National Institute of Biomedical Genomics, Kalyani, India. ma1@nibmg.ac.in.ORCID http://orcid.org/0000-0001-8013-7426

Funding

Council of Scientific and Industrial Research (CSIR) No. 09/1033(12191)/2021-EMR-I
6 · The paper itself

Abstract

Desminopathies are a heterogeneous group of myofibrillar myopathies defined by the presence of desmin-positive aggregates that compromise cytoskeletal integrity in skeletal and cardiac muscle. Although desmin knockout models and several truncating mutations typically result in a functional null phenotype without inclusion body formation, the molecular consequences of specific stop-gain variants remain poorly understood. In this study, we investigated the pathogenic mechanism of a novel Desmin (DES) nonsense mutation, NM_001927.4:c.448 C > T; p.(Arg150Stop), previously identified in an Indian patient with congenital myopathy. This premature stop codon lies within the Linker 1 A domain and is predicted to generate a truncated protein lacking the C-terminal tail. To delineate its functional consequences, we used two complementary experimental approaches: transient overexpression of the Arg150Stop mutant in skeletal and cardiac myocytes, and a CRISPR/Cas9-engineered homozygous Arg150stop cardiomyocyte line (Des

Identifiers

PMID42248875
PMCPMC13458698

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.